newsfilter
← Latest News
PR Newswire·

Innocan Pharma Reports Success in a Pre-Clinical Trial of a Liposomal-CBD Injection on a Paralyzed Goat

HERZLIYA, Israel and CALGARY, Alberta, May 8, 2023 /CNW/ -- Innocan Pharma Corporation (CSE:INNO) (FSE: IP4) (OTCQB:INNPF) (the "Company" or "Innocan") a leading pharmaceutical and biotech company, is